Back to search

Netherlands· NL-968a493fb138

Isteranda 1,5 mg tabletten

A levonorgestrel product containing levonorgestrel, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC G03AD01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedIsteranda 1,5 mg tablettenATCG03AD01REGISTER NO.NL-968a493fb138PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Levonorgestrel is registered in 14 of 19 countries.

Countries holding a registration under ATC G03AD01 (levonorgestrel), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Levonorgestrel · ATC G03AD01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levonorgestrel costs, country by country.

Normalised to the WHO defined daily dose (1.5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Levonorgestrel · price per daily dose (1.5 mg)

USD · FX 28 Sept 2026

  • US United States$6.33 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LEVONORGESTREL
Manufacturer
Sandoz B.V.
Country
Netherlands (NL)
ATC code
G03AD01
ATC class
Levonorgestrel
Defined daily dose
1.5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    111889

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

222 interactions on record for levonorgestrel.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levonorgestrel · interactions on record

222 records

  • 16 severe
  • 143 moderate
  • 7 minor
  • 56 info

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • GriseofulvinD01AA08severe
  • GriseofulvinD01BA01severe
  • AcitretinD05BB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levonorgestrel in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levonorgestrel products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Jaydess, Kyleena
  • Belgium · Jaydess, Justine
  • Bulgaria · Ескапел, Ескапеле
  • Cyprus · Levosert, Levosert One
  • Czechia · Egianti, Escapelle
  • Germany · 28 Mini, Jaydess
  • Denmark · Frivelle, Jaydess
  • Estonia · Avodele, Donasert
  • Spain · Cumbran, Jaydess
  • Finland · Jadelle, Jadelle Sine Inserter
  • France · Donasert, Jaydess
  • United Kingdom (Northern Ireland) · Almus Emergency Contraceptive, Emerres
  • Greece · Levonorgestrel Richter, Mirena
  • Croatia · Escapelle, Levosert
  • Hungary · Empil, Escapelle
  • Ireland · Jaydess, Kyleena
  • Iceland · Jaydess, Kyleena
  • Italy · Benilexa, Escapelle
  • Lithuania · Avodele, Cadele
  • Luxembourg · Jaydess, Levonortis
  • Latvia · Avodele, Escapelle
  • Malta · Escapelle, Jaydess
  • Norway · Jaydess, Kyleena
  • Poland · Escapelle, Kyleena
  • Portugal · Cumbran, Gestanor
  • Romania · Apreg, Emergana
  • Sweden · Frivelle, Jaydess
  • Slovenia · Escapelle, Kyleena
  • Slovakia · Apreg, Escapelle

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b2142c17-d82b-474f-a13e-8a046db332ce
GET /v1/drugs/b2142c17-d82b-474f-a13e-8a046db332ce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h111889_smpc.pdf",
  "strength": null,
  "atc_label": "Levonorgestrel",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg111889",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLOXAMEER 188"
  ],
  "substances": [
    "LEVONORGESTREL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h111889.pdf",
  "authorised_at": "2014/04/30",
  "procedure_number": "NL/H/2656/001",
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "111889",
  "additional_monitoring": "N"
}

See everything about levonorgestrel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.